InvestorsHub Logo
Followers 187
Posts 9484
Boards Moderated 0
Alias Born 07/22/2015

Re: None

Thursday, 05/05/2016 10:03:07 PM

Thursday, May 05, 2016 10:03:07 PM

Post# of 713948
The fact that the sp has dropped disproportionately than the biotech index and peers percentage wise is driven by the short's narrative that NWBO is running out of cash and has to resort to toxic financing and RS. This trend will continue until something changes the dynamics.

Could that something be BMY and MRK taking a stake in NWBO and that negotiations are going behind the scene? This would provide the funding for the trials once for all. Last year Celgene injected 1 billion into JUNO so it's not entirely improbable.

Wishful thinking?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News